DrugCite
Search

ABCIXIMAB

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Abciximab Adverse Events Reported to the FDA Over Time

How are Abciximab adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Abciximab, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Abciximab is flagged as the suspect drug causing the adverse event.

Most Common Abciximab Adverse Events Reported to the FDA

What are the most common Abciximab adverse events reported to the FDA?

Coronary Artery Stenosis
150 (3.95%)
Myocardial Infarction
112 (2.95%)
Coronary Artery Disease
110 (2.89%)
Thrombocytopenia
94 (2.47%)
Ventricular Fibrillation
76 (2%)
Gastrointestinal Haemorrhage
68 (1.79%)
Haemoglobin Decreased
65 (1.71%)
Incorrect Route Of Drug Administrat...
65 (1.71%)
Cardiac Failure
58 (1.53%)
Atrial Fibrillation
53 (1.39%)
Cardiac Arrest
49 (1.29%)
Show More Show More
Cardiogenic Shock
48 (1.26%)
Chest Pain
38 (1%)
Pulmonary Oedema
36 (.95%)
Myocardial Ischaemia
35 (.92%)
Hypotension
34 (.89%)
Ventricular Tachycardia
33 (.87%)
Haemorrhage
32 (.84%)
Pneumonia
32 (.84%)
Post Procedural Complication
32 (.84%)
Drug Interaction
31 (.82%)
Ejection Fraction Decreased
31 (.82%)
Coronary Artery Occlusion
30 (.79%)
Haematoma
27 (.71%)
Haematocrit Decreased
26 (.68%)
Angina Unstable
24 (.63%)
Cardiac Tamponade
24 (.63%)
Dyspnoea
24 (.63%)
Pericardial Effusion
24 (.63%)
Acute Myocardial Infarction
23 (.61%)
Bradycardia
21 (.55%)
Cardiac Failure Congestive
21 (.55%)
Coronary Artery Thrombosis
21 (.55%)
Death
20 (.53%)
Mitral Valve Incompetence
20 (.53%)
Procedural Complication
20 (.53%)
Shock Haemorrhagic
20 (.53%)
Dizziness
19 (.5%)
Pleural Effusion
19 (.5%)
Retroperitoneal Haemorrhage
19 (.5%)
Anaemia
18 (.47%)
Blood Glucose Increased
18 (.47%)
Brain Oedema
17 (.45%)
Cerebral Haemorrhage
17 (.45%)
Cerebrovascular Accident
17 (.45%)
Haematemesis
17 (.45%)
Haemorrhage Intracranial
17 (.45%)
Angina Pectoris
16 (.42%)
Arteriosclerosis Coronary Artery
16 (.42%)
Ischaemia
16 (.42%)
Multi-organ Disorder
16 (.42%)
Respiratory Failure
16 (.42%)
Puncture Site Haemorrhage
15 (.39%)
Renal Failure
15 (.39%)
Acute Respiratory Distress Syndrome
14 (.37%)
Diarrhoea
14 (.37%)
Fall
14 (.37%)
General Physical Health Deteriorati...
14 (.37%)
Hypertension
14 (.37%)
Pericardial Haemorrhage
14 (.37%)
Platelet Count Decreased
14 (.37%)
Subarachnoid Haemorrhage
14 (.37%)
Ventricular Dysfunction
14 (.37%)
Atrioventricular Block Complete
13 (.34%)
Bronchopneumonia
13 (.34%)
Intracardiac Thrombus
13 (.34%)
Multi-organ Failure
13 (.34%)
Myocardial Rupture
13 (.34%)
Renal Impairment
13 (.34%)
Blood Creatine Phosphokinase Mb Inc...
12 (.32%)
Blood Pressure Decreased
12 (.32%)
Bronchial Haemorrhage
12 (.32%)
Cardiac Aneurysm
12 (.32%)
Dilatation Ventricular
12 (.32%)
Renal Failure Acute
12 (.32%)
Tachycardia
12 (.32%)
Thrombosis
12 (.32%)
Urinary Bladder Haemorrhage
12 (.32%)
Ventricular Hypokinesia
12 (.32%)
Condition Aggravated
11 (.29%)
Electrocardiogram St Segment Elevat...
11 (.29%)
Epistaxis
11 (.29%)
Haemodynamic Instability
11 (.29%)
Injection Site Haemorrhage
11 (.29%)
Left Ventricular Failure
11 (.29%)
Nausea
11 (.29%)
Blood Creatine Phosphokinase Increa...
10 (.26%)
Cardiac Procedure Complication
10 (.26%)
Haematuria
10 (.26%)
Haemorrhagic Transformation Stroke
10 (.26%)
Pneumothorax
10 (.26%)
Stent Occlusion
10 (.26%)
Ventricular Septal Defect
10 (.26%)
Chronic Obstructive Pulmonary Disea...
9 (.24%)
Dilatation Atrial
9 (.24%)
Haemoptysis
9 (.24%)
Intraventricular Haemorrhage
9 (.24%)
Post Procedural Haemorrhage
9 (.24%)
Productive Cough
9 (.24%)
Pulmonary Alveolar Haemorrhage
9 (.24%)
Pulmonary Congestion
9 (.24%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Abciximab, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Abciximab is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Abciximab

What are the most common Abciximab adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Abciximab, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Abciximab is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Abciximab According to Those Reporting Adverse Events

Why are people taking Abciximab, according to those reporting adverse events to the FDA?

Acute Myocardial Infarction
629
Anticoagulant Therapy
158
Myocardial Infarction
72
Drug Use For Unknown Indication
30
Thrombosis Prophylaxis
27
Percutaneous Coronary Intervention
26
Show More Show More
Coagulopathy
17
Angioplasty
15
Embolism
12
Coronary Angioplasty
11
Thrombosis
9
Acute Coronary Syndrome
8
Basilar Artery Occlusion
7
Phlebothrombosis
7
Product Used For Unknown Indication
7
Stent Placement
7
Ill-defined Disorder
6
Coronary Arterial Stent Insertion
6
Cerebrovascular Accident
5
Surgery
4
Ischaemic Stroke
4
Coronary Artery Thrombosis
3
Coronary Artery Occlusion
2
Coronary Artery Disease
2
Embolism Arterial
2
Intracranial Aneurysm
2
Cardiovascular Event Prophylaxis
2
Kawasakis Disease
2
Cardiogenic Shock
2
Catheterisation Cardiac
2
Prophylaxis
2
Coronary Artery Surgery
2
Angina Unstable
2
Procedural Complication
1
Antiplatelet Therapy
1
Drug Exposure During Pregnancy
1
Thrombectomy
1
Gastrointestinal Haemorrhage
1
Angiogram
1
Carotid Artery Stent Insertion
1
Cardiovascular Disorder
1
Thrombosis In Device
1
Arterial Therapeutic Procedure
1
Angina Pectoris
1
Cardiac Operation
1

Drug Labels

LabelLabelerEffective
ReoproEli Lilly and Company06-SEP-11

Abciximab Case Reports

What Abciximab safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Abciximab. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Abciximab.